Results 231 to 240 of about 481,083 (295)

Respiratory Health Impacts from Natural Disasters and Other Extreme Weather Events: The Role of Environmental Stressors on Asthma and Allergies. [PDF]

Curr Allergy Asthma Rep
Chou CK, Winker R, Rebuli ME, Moran T, Rager JE.   +4 more
europepmc   +1 more source

Multi‐Method Geophysical Surveys Between and Around the Kerlescan and the Manio Megalithic Alignments in Carnac (Morbihan, France)

Archaeological Prospection, EarlyView.
ABSTRACT The Carnac alignments in Morbihan (France) are among the most famous Neolithic sites of the world. Paradoxically, they have benefited little from a thorough renewal of archaeological data over the past century. There are many reasons for this, but it is mainly because the site has been regarded more as a monument to visit and protect than as ...
Guillaume Bruniaux, Vivien Mathé, Olivier Agogué, Sylvia Lopez, Philippe Paillou, Reena Perschke, Vincent Ard   +6 more
wiley   +1 more source

Ecological Threats and Cultural Systems : Epidemics and Natural Disasters Do Not Predict Collectivism. [PDF]

Hum Nat
Shapouri S, Rafiee Y.
europepmc   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study

Arthritis &Rheumatology, EarlyView.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, for the TULIP‐SC investigators   +12 more
wiley   +1 more source

The role of psychiatry in areas affected by natural disasters. [PDF]

Braz J Psychiatry
Weber CAT, da Silva AG.
europepmc   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

Arthritis &Rheumatology, EarlyView.
Objective To evaluate the efficacy and safety of guselkumab, an interleukin‐23p19 subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor (TNF) inhibitor.
Alexis Ogdie, Joseph F. Merola, Philip J. Mease, Christopher T. Ritchlin, Jose U. Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D. Chakravarty, Wayne Langholff, Yanli Wang, Jie Shao, Yevgeniy Krol, Alice B. Gottlieb   +12 more
wiley   +1 more source

VHA Support for Home Health Agency Staff and Patients During Natural Disasters. [PDF]

Fed Pract
Wyte-Lake T, Dobalian A, Solorzano E, Hall LM, Franzosa E.   +4 more
europepmc   +1 more source

24-hour movement behaviours and health outcomes among forcibly displaced children affected by conflict or natural disasters: a scoping review. [PDF]

BMC Public Health
Abdeta C, Cliff DP, Toledo-Vargas M, Okely AD.   +3 more
europepmc   +1 more source